According to a new report, published by KBV research, The Global Temperature Modulation Devices Market size is expected to reach $4.4 billion by 2030, rising at a market growth of 7.1% CAGR during the forecast period.
The Convective patient warming systems segment is exhibiting a CAGR of 6.3 % during the forecast period. Convective warming systems help counteract the cooling effect of operating rooms and anesthesia, reducing the risk of hypothermia. Maintaining core body temperature with convective warming can help stabilize cardiovascular function. It reduces the risk of arrhythmias, decreases oxygen consumption, and helps maintain blood pressure within the desired range, which is especially important for patients with cardiovascular issues. Convective warming systems can result in cost savings for healthcare facilities.
The North America region dominated the Global Temperature Modulation Devices Market, by region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.7 Billion by 2030. The Europe market is anticipated to grow a CAGR of 6.7% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 7.9% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/temperature-modulation-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Stryker Corporation, Gentherm Incorporated (Gentherm Medical), Belmont Medical Technologies (Audax Managment Company, LLC), Becton, Dickinson and Company, 3M Company, The Surgical Company, ICU Medical, Inc., Smiths Group plc, General Electric Company and Barkey GmbH & Co. KG.
By Product
By Geography
Companies Profiled
Unique Offerings 
